Acytronix is an ETH Zurich spin-off developing a scalable electro-immunopurification platform for rapid, high-purity isolation of extracellular vesicles (EVs) and other biological nanoparticles directly from complex biological fluids. Our portable and high-throughput technology addresses a major bottleneck limiting EV-based diagnostics, therapeutics, and regenerative applications. To date, Acytronix has deployed over 1,000 purification cartridges to academic laboratories, hospitals, and biotech companies working in the EV field. Beyond research-use applications, the company is expanding toward clinical workflows, liquid biopsy diagnostics, and bioactive EV-enabled products in regenerative medicine and advanced cosmeceuticals.
No news
No milestones
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.acytronix.ch
Headquarter:
Schlieren
Foundation Date:
May 2024
Technology:
Sectors: